{"count": 10, "results": [{"_id": "37847357", "pmid": 37847357, "pmcid": "PMC10676344", "title": "Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways", "journal": "Drugs R D", "authors": ["Li G", "Yao J", "Lu Z", "Yu L", "Chen Q", "Ding L", "Fang Z", "Li Y", "Xu B"], "date": "2023-10-17T00:00:00Z", "doi": "10.1007/s40268-023-00442-6", "meta_date_publication": "2023 Oct 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50280.08, "text_hl": "On the basis of these in vitro results, we were encouraged to detect the anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ activity of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in vivo. ", "citations": {"NLM": "Li G, Yao J, Lu Z, Yu L, Chen Q, Ding L, Fang Z, Li Y, Xu B. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways Drugs R D. 2023 Oct 17;():. PMID: 37847357", "BibTeX": "@article{37847357, title={Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways}, author={Li G and Yao J and Lu Z and Yu L and Chen Q and Ding L and Fang Z and Li Y and Xu B}, journal={Drugs R D}}"}}, {"_id": "11877052", "pmid": 11877052, "title": "[Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].", "journal": "Zhonghua Xue Ye Xue Za Zhi", "authors": ["Ren H", "Zhang N", "Xu H", "Lu D"], "date": "2001-02-01T00:00:00Z", "meta_date_publication": "2001 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "72-5", "score": 50066.953, "text_hl": "[Inhibition of proliferation and induction of apoptosis by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @CELLLINE_CVCL:0004 @@@K562@@@ @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ cell line].", "citations": {"NLM": "Ren H, Zhang N, Xu H, Lu D. [Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line]. Zhonghua Xue Ye Xue Za Zhi. 2001 Feb;22(2):72-5. PMID: 11877052", "BibTeX": "@article{11877052, title={[Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].}, author={Ren H and Zhang N and Xu H and Lu D}, journal={Zhonghua Xue Ye Xue Za Zhi}, volume={22}, number={2}, pages={72-5}}"}}, {"_id": "31452046", "pmid": 31452046, "title": "Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.", "journal": "Mol Biol Rep", "authors": ["Jang J", "Lee J", "Jang JH", "Jung CW", "Park S"], "date": "2019-12-01T00:00:00Z", "doi": "10.1007/s11033-019-05019-8", "meta_date_publication": "2019 Dec", "meta_volume": "46", "meta_issue": "6", "meta_pages": "5859-5866", "score": 50064.453, "text_hl": "Anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on NRASG12D mutant @DISEASE_Leukemia_Myeloid_Acute @DISEASE_MESH:D015470 @@@acute myeloid leukemia@@@ cells.", "citations": {"NLM": "Jang J, Lee J, Jang JH, Jung CW, Park S. Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells. Mol Biol Rep. 2019 Dec;46(6):5859-5866. PMID: 31452046", "BibTeX": "@article{31452046, title={Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells.}, author={Jang J and Lee J and Jang JH and Jung CW and Park S}, journal={Mol Biol Rep}, volume={46}, number={6}, pages={5859-5866}}"}}, {"_id": "7614073", "pmid": 7614073, "title": "The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.", "journal": "J Investig Med", "authors": ["Newman A", "Clutterbuck RD", "DeLord C", "Powles RL", "Catovsky D", "Millar JL"], "date": "1995-06-01T00:00:00Z", "meta_date_publication": "1995 Jun", "meta_volume": "43", "meta_issue": "3", "meta_pages": "269-74", "score": 50061.81, "text_hl": "The sensitivity of @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ bone marrow to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is lost at remission: a potential purging agent for autologous bone marrow transplantation.", "citations": {"NLM": "Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. J Investig Med. 1995 Jun;43(3):269-74. PMID: 7614073", "BibTeX": "@article{7614073, title={The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.}, author={Newman A and Clutterbuck RD and DeLord C and Powles RL and Catovsky D and Millar JL}, journal={J Investig Med}, volume={43}, number={3}, pages={269-74}}"}}, {"_id": "18310894", "pmid": 18310894, "title": "The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia.", "journal": "Biol Pharm Bull", "authors": ["Tomiyama N", "Matzno S", "Kitada C", "Nishiguchi E", "Okamura N", "Matsuyama K"], "date": "2008-03-01T00:00:00Z", "doi": "10.1248/bpb.31.369", "meta_date_publication": "2008 Mar", "meta_volume": "31", "meta_issue": "3", "meta_pages": "369-74", "score": 50059.46, "text_hl": "Further studies revealed the particular mechanism of action of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@-induced apoptosis in @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@. ", "citations": {"NLM": "Tomiyama N, Matzno S, Kitada C, Nishiguchi E, Okamura N, Matsuyama K. The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia. Biol Pharm Bull. 2008 Mar;31(3):369-74. PMID: 18310894", "BibTeX": "@article{18310894, title={The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia.}, author={Tomiyama N and Matzno S and Kitada C and Nishiguchi E and Okamura N and Matsuyama K}, journal={Biol Pharm Bull}, volume={31}, number={3}, pages={369-74}}"}}, {"_id": "25262449", "pmid": 25262449, "title": "Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition.", "journal": "Leuk Res", "authors": ["Ahmed TA", "Hayslip J", "Leggas M"], "date": "2014-11-01T00:00:00Z", "doi": "10.1016/j.leukres.2014.09.002", "meta_date_publication": "2014 Nov", "meta_volume": "38", "meta_issue": "11", "meta_pages": "1350-7", "score": 50054.914, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ interacts synergistically with @CHEMICAL_tipifarnib @CHEMICAL_MESH:C402769 @@@tipifarnib@@@ to induce apoptosis in @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ cells through the disruption of RAS membrane localization and @GENE_MAPK1 @GENE_5594 @@@ERK@@@ pathway inhibition.", "citations": {"NLM": "Ahmed TA, Hayslip J, Leggas M. Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition. Leuk Res. 2014 Nov;38(11):1350-7. PMID: 25262449", "BibTeX": "@article{25262449, title={Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition.}, author={Ahmed TA and Hayslip J and Leggas M}, journal={Leuk Res}, volume={38}, number={11}, pages={1350-7}}"}}, {"_id": "25316568", "pmid": 25316568, "title": "Simvastatin induces NFkappaB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells.", "journal": "Biochem Pharmacol", "authors": ["Chen YJ", "Chang LS"], "date": "2014-12-15T00:00:00Z", "doi": "10.1016/j.bcp.2014.09.026", "meta_date_publication": "2014 Dec 15", "meta_volume": "92", "meta_issue": "4", "meta_pages": "530-43", "score": 50052.473, "text_hl": "The aim of the present study was to explore the signaling pathways associated with the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @GENE_MMP2 @GENE_4313 @@@matrix metalloproteinase-2@@@ (@GENE_MMP2 @GENE_4313 @@@MMP-2@@@)/@GENE_MMP9 @GENE_4318 @@@MMP-9@@@ expression in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ @CELLLINE_CVCL:0004 @@@K562@@@ cells. ", "citations": {"NLM": "Chen YJ, Chang LS. Simvastatin induces NFkappaB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells. Biochem Pharmacol. 2014 Dec 15;92(4):530-43. PMID: 25316568", "BibTeX": "@article{25316568, title={Simvastatin induces NFkappaB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells.}, author={Chen YJ and Chang LS}, journal={Biochem Pharmacol}, volume={92}, number={4}, pages={530-43}}"}}, {"_id": "26855507", "pmid": 26855507, "title": "Changes of Apolipoprotein M Gene Expression During the Cell Differentiation and Apoptosis Induced by Simvastatin in Combination with All-Trans Retinoic Acid in Human Promyelocytic Leukemia Cell Line NB4.", "journal": "Indian J Hematol Blood Transfus", "authors": ["Gu W", "Xiang L", "Jiang T", "Luo G", "Wei J", "Cen J", "Chen Z", "Qiu G", "Zeng M", "Zhang X"], "date": "2016-03-01T00:00:00Z", "doi": "10.1007/s12288-015-0515-4", "meta_date_publication": "2016 Mar", "meta_volume": "32", "meta_issue": "1", "meta_pages": "54-61", "score": 50051.758, "text_hl": "Together these results show that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@ has anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ properties by itself and that combined therapy may have a place in the current anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ arsenal. ", "citations": {"NLM": "Gu W, Xiang L, Jiang T, Luo G, Wei J, Cen J, Chen Z, Qiu G, Zeng M, Zhang X. Changes of Apolipoprotein M Gene Expression During the Cell Differentiation and Apoptosis Induced by Simvastatin in Combination with All-Trans Retinoic Acid in Human Promyelocytic Leukemia Cell Line NB4. Indian J Hematol Blood Transfus. 2016 Mar;32(1):54-61. PMID: 26855507", "BibTeX": "@article{26855507, title={Changes of Apolipoprotein M Gene Expression During the Cell Differentiation and Apoptosis Induced by Simvastatin in Combination with All-Trans Retinoic Acid in Human Promyelocytic Leukemia Cell Line NB4.}, author={Gu W and Xiang L and Jiang T and Luo G and Wei J and Cen J and Chen Z and Qiu G and Zeng M and Zhang X}, journal={Indian J Hematol Blood Transfus}, volume={32}, number={1}, pages={54-61}}"}}, {"_id": "11478407", "pmid": 11478407, "title": "Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.", "journal": "J Investig Med", "authors": ["Lishner M", "Bar-Sef A", "Elis A", "Fabian I"], "date": "2001-07-01T00:00:00Z", "doi": "10.2310/6650.2001.33896", "meta_date_publication": "2001 Jul", "meta_volume": "49", "meta_issue": "4", "meta_pages": "319-24", "score": 50049.6, "text_hl": "These findings may open new avenues in both the laboratory and clinical research of the treatment of @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@.", "citations": {"NLM": "Lishner M, Bar-Sef A, Elis A, Fabian I. Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines. J Investig Med. 2001 Jul;49(4):319-24. PMID: 11478407", "BibTeX": "@article{11478407, title={Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.}, author={Lishner M and Bar-Sef A and Elis A and Fabian I}, journal={J Investig Med}, volume={49}, number={4}, pages={319-24}}"}}, {"_id": "25161239", "pmid": 25161239, "pmcid": "PMC4147909", "title": "Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis", "journal": "Bioinformatics", "authors": ["Khan SA", "Virtanen S", "Kallioniemi OP", "Wennerberg K", "Poso A", "Kaski S"], "date": "2014-09-01T00:00:00Z", "doi": "10.1093/bioinformatics/btu456", "meta_date_publication": "2014 Sep 1", "meta_volume": "30", "meta_issue": "17", "meta_pages": "i497-504", "score": 50031.36, "text_hl": "Furthermore, our analysis revealed that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, a @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@-lowering drug, has a @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@-specific response similar to a range of corticosteroids. ", "citations": {"NLM": "Khan SA, Virtanen S, Kallioniemi OP, Wennerberg K, Poso A, Kaski S. Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis Bioinformatics. 2014 Sep 1;30(17):i497-504. PMID: 25161239", "BibTeX": "@article{25161239, title={Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis}, author={Khan SA and Virtanen S and Kallioniemi OP and Wennerberg K and Poso A and Kaski S}, journal={Bioinformatics}, volume={30}, number={17}, pages={i497-504}}"}}]}